Optimising Asparaginase Use and Managing Hypersensitivity in A ustralasia—A Clinical Practice Guideline From the A ustralian and N ew Z ealand Children's Haematology/Oncology Group
Matthew O’Connor, Michelle Martin, Sarah Trinder, Draga Barbaric et autres
BACKGROUND: Asparaginase is a critical component of modern multi-agent chemotherapy regimens for paediatric acute lymphoblastic leukaemia and lymphoblastic lymphoma, with inadequate exposure leading to inferior patient outcomes. OBJECTIVES: To develop a clinical practice guideline for the use of asparaginase products in the …
au, nz (code pays fourni par la source)